Anand V Kulkarni
@AnandVKulkarni2
Hepatologist @ Asian Institute of Gastroenterology. Interests in ALD, ACLF & HCC
ID:725476555686731777
28-04-2016 00:07:44
3,7K Tweets
3,1K Followers
2,6K Following
🔥Off the press
Check out : BRAINFOOD : A proof of concept 📝using 🏘️ delivered medically tailored meals in cirrhosis with HE
🔸 Feasible
🔸📈 ANT, Stroop, LFI
From Elliot Tapper Jasmohan Bajaj
👇 M PREMKUMAR Anand V Kulkarni Sanchit Liver Fellow Network jcehepatology.com/article/S0973-…
Grateful to Journal of Clinical and Experimental Hepatology for publishing our study
The dream - short term medically tailored meals to support patients with cirrhosis
I’m excited to share our work from Weinman's Lab recently got published in HEPATOLOGY Journal and it’s online now!! journals.lww.com/hep/pages/arti…
We are trying to understand the role of Kupffer cells in maintaining homeostasis during alcohol associated liver disease.
Important study. Next important Q to answer is what should be the interval for surveillance MRs. #livertwitter
#LiverTwitter
Great study in Hepatology Communications showing
🏠💪 Home Exercise
💊 BCAA: branched-chain amino acids
🦠 Probiotica
✅benefit #Cirrhosis patients by decreasing
- 👋🦵 risk of falls
- 🏥🚑 ER room visits
Link Online now.
Alimentary Pharmacology & Therapeutics | Pharmacology Journal | Wiley Online Library onlinelibrary.wiley.com/doi/10.1111/ap…
Iva Košuta Anand V Kulkarni #livertwitter Steven Bollipo
🔸Check out the Use of bacterial DNA concentration in ascites as a marker for SBP
Thomas Berg and colleagues
👇 Journal of Clinical and Experimental Hepatology EASLnews #livertwitter Anil Anand V Kulkarni M PREMKUMAR Dr Nipun Verma Liver Fellow Network jcehepatology.com/article/S0973-…
Hot off the press 🔥 Comprehensive overview of the critically ill patient with Cirrhosis. Kosuta I, Premkumar M, Reddy KR. Aliment Pharmacol Ther. 2024;00:1–21. doi.org/10.1111/apt.18… Iva Košuta Anand V Kulkarni Ajay Duseja Anand V Kulkarni Elliot Tapper Rohit Loomba #livertwitter
🤩We summarized the existing pharmacological therapies for #portalhtn in #cirrhosis Juan G Abraldes
🗝️Etiological tx
✅NSBB
✅Vasoactive agents
✅Statin & metformin
In Press here: shorturl.at/iGKRW
#Livertwitter #GITwitter #MedTwitter #medstudenttwitter
Important study for Asian physicians! HAV is a common cause for ALF in here. Who are these individuals?
➡️➡️High ammonia
And leucocyte predict ALF. #livertwitter
Join us to know the best abstracts presented at APASL News by Manasa Alla &. Dr Shantan #livertwitter
Clinicians from our Department of Hepatology will present the best of science that was showcased at the #APASL2024 during this week's Clinician Scientist Interactive Session. #LiverDiseases #CLD #Cirrhosis #HCC #AIGHospitals #AHF
🔸Non Invasive prediction of EVs in Obese MASLD Cirrhosis
🔸Looking beyond TE
🔸We looked and compared MRE and ARFI
🔸MRE with Platelets 💪
🔸Still needs better models
❎Absence of HVPG ❎TE LSM
🔸Looking ⏩ TE vs ARFI vs MRE with HVPG
link.springer.com/article/10.100…
Apollo Multispeciality Hospitals, Kolkata
'Once the current LSM is known, previous LSM values do not add to the prediction of LREs in cACLD patients'
#Livertwitter #GItwitter AASLD The Baveno Cooperation: an EASL Consortium EASLnews APASL News
👉shorturl.at/tENU8
Congratulations Rakhi Maiwall for leading the APASL News AARC_APASL guidelines on AKI. Beautifully crafted!
Global Aki Salvatore Piano Kavish Patidar Grace Wong Juan Pablo (JP) Arab, MD Atoosa Rabiee Akshata Moghe MD, PhD Deepika Devuni MD #livertwitter
1 month to go...waiting for an academic extravaganza
Akash Roy Sridhar Sundaram MD, DM, FISG Dr Rajesh Puri Mahesh Goenka Anand V Kulkarni Dr Kaushal Madan Ajay Duseja Dr. Rupa Banerjee Arun Valsan Rajesh Sasidharan Sahaj Rathi MD, DM, MRCP